Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening

被引:16
|
作者
Ramirez, David [1 ]
Concha, Guierdy [2 ]
Arevalo, Barbara [3 ]
Prent-Penaloza, Luis [4 ,5 ]
Zuniga, Leandro [2 ]
Kiper, Aytug K. [6 ]
Rinne, Susanne [6 ]
Reyes-Parada, Miguel [7 ,8 ]
Decher, Niels [6 ,9 ,10 ]
Gonzalez, Wendy [11 ,12 ]
Caballero, Julio [11 ]
机构
[1] Univ Autonoma Chile, Fac Ciencias Salud, Inst Ciencias Biomed, El Llano Subercaseaux 2801,Piso 5, Santiago 8900000, Chile
[2] Univ Talca, Escuela Med, PIA CG, CIM, 2 Norte 685, Talca 3460000, Chile
[3] Univ Tecnol Chile Inacap, Informat & Telecomunicac, Sede Talca, Av San Miguel 3496, Talca 3460000, Chile
[4] Univ Talca, Inst Chem Nat Resources, Fac Engn, Organ Synth Lab,PhD Appl Sci, 1 Poniente 1141, Talca 3460000, Chile
[5] Univ Talca, Inst Chem Nat Resources, Fac Engn, Biol Act LSO Act Bio,PhD Appl Sci, 1 Poniente 1141, Talca 3460000, Chile
[6] Philipps Univ Marburg, Vegetat Physiol, Inst Physiol & Pathophysiol, Deutschhausstr 2, D-35037 Marburg, Germany
[7] Univ Santiago Chile, Fac Ciencias Med, Escuela Med, Ctr Invest Biomed & Aplicada CIBAP, Av Libertador Bernardo OHiggins 3677, Santiago 8900000, Chile
[8] Univ Autonoma Chile, Fac Ciencias Salud, Ave Pedro de Valdivia 425, Santiago 8900000, Chile
[9] Univ Marburg, CMBB, D-35037 Marburg, Germany
[10] Justus Liebig Univ Giessen, D-35037 Marburg, Germany
[11] Univ Talca, CBSM, 1 Poniente 1141, Talca 3460000, Chile
[12] Univ Talca, Millennium Nucleus Ion Channels Associated Dis Mi, Talca 3460000, Chile
关键词
TASK-3; channel; drug design; TASK channels blockers; pharmacophore-based virtual screening; lead optimization; POTASSIUM CHANNELS; K+ CHANNEL; MOLECULAR DOCKING; CRYSTAL-STRUCTURE; BINDING; INHIBITORS; TRAAK; MEMBRANE; PORE; SITE;
D O I
10.3390/ijms20164014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TASK-3 is a two-pore domain potassium (K-2P) channel highly expressed in the hippocampus, cerebellum, and cortex. TASK-3 has been identified as an oncogenic potassium channel and it is overexpressed in different cancer types. For this reason, the development of new TASK-3 blockers could influence the pharmacological treatment of cancer and several neurological conditions. In the present work, we searched for novel TASK-3 blockers by using a virtual screening protocol that includes pharmacophore modeling, molecular docking, and free energy calculations. With this protocol, 19 potential TASK-3 blockers were identified. These molecules were tested in TASK-3 using patch clamp, and one blocker (DR16) was identified with an IC50 = 56.8 +/- 3.9 mu M. Using DR16 as a scaffold, we designed DR16.1, a novel TASK-3 inhibitor, with an IC50 = 14.2 +/- 3.4 mu M. Our finding takes on greater relevance considering that not many inhibitory TASK-3 modulators have been reported in the scientific literature until today. These two novel TASK-3 channel inhibitors (DR16 and DR16.1) are the first compounds found using a pharmacophore-based virtual screening and rational drug design protocol.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screening
    Kim, Nam Doo
    Chun, Haarin
    Park, Sang Jin
    Yang, Jae Won
    Kim, Jong Woo
    Ahn, Soon Kil
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3329 - 3334
  • [2] Identification of Novel Rab27a/Melanophilin Blockers by Pharmacophore-Based Virtual Screening
    Joung, Jong Young
    Lee, Ha Yeon
    Park, Jongil
    Lee, Jee-Young
    Chang, Byung Ha
    No, Kyoung Tai
    Nam, Ky-Youb
    Hwang, Jae Sung
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2014, 172 (04) : 1882 - 1897
  • [3] Identification of Novel Rab27a/Melanophilin Blockers by Pharmacophore-Based Virtual Screening
    Jong Young Joung
    Ha Yeon Lee
    Jongil Park
    Jee-Young Lee
    Byung Ha Chang
    Kyoung Tai No
    Ky-Youb Nam
    Jae Sung Hwang
    Applied Biochemistry and Biotechnology, 2014, 172 : 1882 - 1897
  • [4] Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening
    Sharma, Jyoti
    Yadav, Divya
    Paliwal, Sarvesh
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (02) : 558 - 572
  • [5] Discovery of novel DPP IV inhibitors: application of pharmacophore-based virtual screening
    Jyoti Sharma
    Divya Yadav
    Sarvesh Paliwal
    Medicinal Chemistry Research, 2013, 22 : 558 - 572
  • [6] Pharmacophore-based virtual screening
    Van Drie, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [7] Pharmacophore-based virtual screening
    Sun, Hongmao
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (10) : 1018 - 1024
  • [8] Pharmacophore-based identification of novel hERG channel blockers of natural origin - Development of a virtual screening workflow and experimental validation
    Kratz, J. M.
    Edtbauer, M.
    Mair, C. E.
    Hering, S.
    Schuster, D.
    Rollinger, J. M.
    PLANTA MEDICA, 2013, 79 (13) : 1113 - 1113
  • [9] Discovery of a Novel 5-HT2A Inhibitor by Pharmacophore-based Virtual Screening
    XIONG Zi-jun1
    2.State Key Laboratory for Drug Research
    3.Department of Pharmacology
    Chemical Research in Chinese Universities, 2011, 27 (04) : 655 - 660
  • [10] Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
    Gallego-Yerga, Laura
    Ochoa, Rodrigo
    Lans, Isaias
    Pena-Varas, Carlos
    Alegria-Arcos, Melissa
    Cossio, Pilar
    Ramirez, David
    Pelaez, Rafael
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4360 - 4372